Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Barrett Esophagus 9Stomach Neoplasms 8Gastroesophageal Reflux 4Gastritis, Atrophic 4Gastrointestinal Neoplasms 2Carcinoma, Hepatocellular 2Adenocarcinoma Of Esophagus 2Weight Loss 1Thrombocythemia, Essential 1Stomach Ulcer 1Primary Myelofibrosis 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Lymphoma, Mantle-Cell 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Fibrosis 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Duodenal Neoplasms 1Deglutition Disorders 1Cholangiocarcinoma 1Adenomatous Polyposis Coli 1Adenocarcinoma of the Esophagogastric Junction 1

Interventions

fludarabine phosphate 21Cyclophosphamide 20Peripheral Blood Stem Cell Transplantation 19Busulfan 16Tacrolimus 14Whole-Body Irradiation 12Methotrexate 12Mycophenolic Acid 11Cyclosporine 11Antilymphocyte Serum 10fludarabine 6Filgrastim 6peginterferon alfa-2a 5ruxolitinib 4Radiotherapy 4Methylprednisolone 4Melphalan 4Flow Cytometry 4Etoposide 4Decitabine 4Aspirin 4Stem Cell Transplantation 3Injections 3Cytogenetic Analysis 3Cytarabine 3Biopsy 3Azacitidine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3merphos 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thrombocythemia, Essential × Endoscopy, Digestive System × Clear all
NCT01816256 2023-07-21

Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms

University Health Network, Toronto

Phase NA Completed
102 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡